TEP-COV

Investigator physician: Pr Antoine VERGER

¹⁸F-FDG PET/CT characterization of brain lesions in young subjects with sequelae of psycho-cognitive disorders in the aftermath of severe Covid-19

Sequelae of psycho-cognitive disorders following severe Covid-19

This is a prospective, monocentric, non-randomized human intervention research stud.

Patients definitively included in the Neurocog-Covid study following an abnormal neuropsychological assessment, and for whom a cerebral MRI is then planned, will be proposed by their neurologist to take part in the PET-COV study.
This involves performing a positron emission tomography scan combined with an ¹⁸F-FDG cerebro-cervico-thoracic PET/CT scan during the brain MRI. A second ¹⁸F-FDG PET/CT scan will be performed at 12 months +/- 3 months from the first visit. Participation in the PET-COV study is over for the patient when he/she leaves the nuclear medicine department, after his/her second ¹⁸F-FDG PET/CT.

The treatment under study: Diagnostic PET/CT au ¹⁸F-FDG
Study status: Terminated
Clinical Trial number: NCT04764721
Funding: Not applicable